Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment, 60643-60644 [2024-16504]
Download as PDF
<![CDATA[
60643
Federal Register / Vol. 89, No. 144 / Friday, July 26, 2024 / Notices
about additional data collection
activities to support this study.
DATES: Comments due August 26, 2024.
The Office of Management and Budget
(OMB) must make a decision about the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing
OPREinfocollection@acf.hhs.gov.
Identify all requests by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: Core components are the
essential functions, principles, and
elements that are judged as being
necessary to produce positive outcomes.
Fatherhood programs usually offer
workshops and case management
services for fathers to provide, for
example, parenting strategies to
strengthen their relationships with their
children, help finding a steady job,
skills to enhance their relationships,
and support dealing with other life or
family challenges they might
experience. Five Fatherhood FIRE grant
recipients are partnering with the
Fatherhood TIES study team to
participate in an implementation and
impact study. The implementation
study will examine how the core
components are implemented and what
fathers think of them. The impact study
will rigorously evaluate whether
promising core components bring about
positive outcomes for fathers and their
families which may include
understanding effects of program
engagement, economic stability, fatherchild relationship quality and coparenting relationship quality.
Initial study (Phase 1) materials,
including consent to participate in the
study, additional baseline information
from program participants, and initial
implementation study data were
Number of
respondents
(total over
request
period)
Instrument
Number of
responses per
respondent
(total over
request
period)
Annual Burden Estimates
Data collection time frames vary by
instrument. Instruments with a star (*)
will be fielded in the first year. The
follow-up survey is anticipated to
continue into early 2027. Therefore, this
request is for two and a half years of
approval and annual burden estimates
reflect this timeframe (total burden/2.5).
Average
burden per
response
(in hours)
Total burden
(in hours)
Annual burden
(in hours)
Staff Interview (including consent) * .....................................
Co-Parent Interview (including consent) * ............................
Father focus group (including consent) * .............................
Photo Voice (collection + focus group + debrief) * ..............
Audio Journaling (collection + debrief) * ..............................
Nine-month Follow-up survey ..............................................
Photo Voice Training * .........................................................
Audio Journaling Training * ..................................................
50
4
80
5
55
1369
5
55
2
1
1
1
1
1
1
1
1
1
1
3.25
1
0.75
2
0.5
100
4
80
16
55
1027
10
28
40
2
32
7
22
411
4
11
Estimated Annual Burden Total ....................................
........................
........................
........................
........................
529
Authority: Section 413 of the Social
Security Act, as amended by the fiscal
year 2017 Consolidated Appropriations
Act, 2017 (Pub. L. 115–31).
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024–16431 Filed 7–25–24; 8:45 am]
BILLING CODE 4184–73–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis, and
STD Prevention and Treatment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
ddrumheller on DSK120RN23PROD with NOTICES1
approved and are in use by the study
team. We are now requesting approval
of Phase 2 data collection materials
including semi-structured interviews,
focus groups, and the participatory
research methods of photo voice and
audio journaling. Audio journaling and
photo voice are participatory research
methods that the study team will use
with up to 60 fathers in total to generate
information about how fathers are
applying knowledge and skills gained
through their participation in the
fatherhood program.
Respondents: Fathers enrolled in the
Fatherhood TIES study, co-parents of
fathers enrolled, and program staff
involved in supporting and
implementing the Fatherhood TIES
study.
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Centers for
Disease Control and Prevention (CDC)/
HRSA Advisory Committee on HIV,
SUMMARY:
VerDate Sep<11>2014
17:17 Jul 25, 2024
Jkt 262001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Viral Hepatitis and STD Prevention and
Treatment (CHAC) has scheduled a
public meeting. Information about
CHAC and the meeting can be found on
the CHAC website at https://
www.cdc.gov/faca/committees/
chachspt.html and the meeting website
at https://targethiv.org/events/chac.
DATES: October 21, 2024, 9 a.m. to 5
p.m. eastern time (ET) and October 22,
2024, 9 a.m. to 3 p.m. ET.
ADDRESSES: This meeting will be hybrid,
held both virtually through Zoom and
in-person at 5600 Fishers Lane in
Rockville, Maryland, 20857. Advance
registration is required to attend. Please
visit the meeting website to register.
Registration will open in August. The
in-person registration deadline is
E:\FR\FM\26JYN1.SGM
26JYN1
ddrumheller on DSK120RN23PROD with NOTICES1
60644
Federal Register / Vol. 89, No. 144 / Friday, July 26, 2024 / Notices
Monday, October 14, 2024, at 5 p.m. ET;
registration for virtual attendance will
remain open. Prior to the meeting, each
individual registrant will receive a
registration confirmation along with an
access link to the virtual meeting
location.
FOR FURTHER INFORMATION CONTACT:
Breana Alsworth, Public Health Analyst,
HIV/AIDS Bureau, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; (301)
443–1134; or CHACAdvisoryComm@
hrsa.gov.
SUPPLEMENTARY INFORMATION: CHAC
provides advice and recommendations
to the Secretary of HHS on policy,
program development, and other
matters of significance concerning the
activities under section 222 of the
Public Health Service Act, 42 U.S.C.
217a.
The purpose of CHAC is to advise the
Secretary of HHS, CDC Director, and
HRSA Administrator regarding
objectives, strategies, policies, and
priorities for the prevention and
treatment of HIV, viral hepatitis, and
other STDs, including surveillance,
epidemiologic, behavioral, health
services, and laboratory research,
identification of policy issues related to
professional education, patient
healthcare delivery, and prevention
services; agency policies regarding
health care delivery, research and
training; strategic issues influencing the
ability of CDC and HRSA to fulfill their
missions’ programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to CDC
and HRSA in their development of
responses to emerging health needs
related to these issues.
During the October 21–22, 2024,
meeting, CHAC will discuss issues
related to re-engaging people with HIV
out of care (including data-to-care
strategies and overcoming barriers to
care), the use of long-acting injectables
for HIV care and treatment and
increasing access to mental health
services for people with HIV and STDs.
Agenda items are subject to change as
priorities dictate. Please refer to the
CHAC meeting information page listed
above for any updated meeting
information.
Members of the public will have the
opportunity to provide comments.
Public participants may also submit
written statements as further described
below. Oral comments will be honored
in the order they are requested and may
be limited as time allows. Requests to
submit a written statement or make oral
comments to CHAC should be sent via
the meeting website at https://
targethiv.org/events/chac after
VerDate Sep<11>2014
17:17 Jul 25, 2024
Jkt 262001
registration has opened. Requests for
oral comment must be received by
October 11, 2024, at 5:00 p.m. ET to be
considered. Written comments may be
submitted to Breana Alsworth
(CHACAdvisoryComm@hrsa.gov) prior
to and up to 10 business days after the
meeting. Visit the meeting information
page for additional details: https://
targethiv.org/events/chac.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Breana Alsworth
(CHACAdvisoryComm@hrsa.gov) at
least 10 business days prior to the
meeting. Since this meeting occurs in a
Federal Government building, attendees
must go through a security check to
enter the building. Non-U.S. Citizen
attendees must notify HRSA of their
planned attendance at least 20 business
days prior to the meeting to facilitate
their entry into the building. All
attendees are required to present
government-issued identification prior
to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–16504 Filed 7–25–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council provides advice on
how to prevent or reduce the burden of
Alzheimer’s disease and related
dementias (ADRD) on people with the
disease and their caregivers. During the
meeting, the Advisory Council
subcommittees will present their
recommendations for adoption by the
full Advisory Council. Each
subcommittee will discuss new
developments in their area. The meeting
will also include presentations on latebreaking findings from recent research
conferences, an update on the CMMI
GUIDE Model, and updates from federal
agencies.
DATES: The meeting will be August 5,
2024, from 9:30 a.m. to 4:30 p.m.
ADDRESSES: The meeting will be a
hybrid of in-person and virtual. The
meeting will be held in the Great Hall
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
of the Hubert H. Humphrey Building,
200 Independence Avenue SW,
Washington, DC 20201. It will also
stream live at www.hhs.gov/live.
Comments: Time is allocated on the
agenda to hear public comments from 4
p.m. to 4:30 p.m. on Monday, August 5.
The time for oral comments will be
limited to two (2) minutes per
individual. To provide a public
comment, please register by emailing
your name to napa@hhs.gov by
Wednesday, July 31. Registered
commenters will receive both a dial-in
number and a link to join the meeting
virtually; individuals will have the
choice to either join virtually via the
link, or to call in only by using the dialin number. Note: There may be a 30–45
second delay in the livestream video
presentation of the conference. For this
reason, if you have pre-registered to
submit a public comment, it is
important to connect to the meeting by
3:45 p.m. to ensure that you do not miss
your name and allotted time when
called. If you miss your name and
allotted time to speak, you may not be
able to make your public comment.
Public commenters will not be admitted
to the virtual meeting before 3:30 p.m.
but are encouraged to watch the meeting
at www.hhs.gov/live. Should you have
questions during the session, please
email napa@hhs.gov and someone will
respond to your message as quickly as
possible.
To ensure accuracy, please submit a
written copy of oral comments for the
record by emailing napa@hhs.gov by
Wednesday, August 7, 2024. These
comments will be shared on the website
and reflected in the meeting minutes.
In lieu of oral comments, formal
written comments may be submitted for
the record by Wednesday, August 7,
2024, to Helen Lamont, Ph.D., OASPE,
200 Independence Avenue SW, Room
424E, Washington, DC 20201.
Comments may also be sent to napa@
hhs.gov. Those submitting written
comments should identify themselves
and any relevant organizational
affiliations.
FOR FURTHER INFORMATION CONTACT:
Helen Lamont, 202–260–6075,
helen.lamont@hhs.gov. Note: The
meeting will be available to the public
live at www.hhs.gov/live.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. app. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting:
Alzheimer’s disease-related dementias,
clinical care, long term care support
services, research, risk reduction,
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 89, Number 144 (Friday, July 26, 2024)]
[Notices]
[Pages 60643-60644]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16504]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis, and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Centers for Disease Control and Prevention
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHAC) has scheduled a public meeting.
Information about CHAC and the meeting can be found on the CHAC website
at https://www.cdc.gov/faca/committees/chachspt.html and the meeting
website at https://targethiv.org/events/chac.
DATES: October 21, 2024, 9 a.m. to 5 p.m. eastern time (ET) and October
22, 2024, 9 a.m. to 3 p.m. ET.
ADDRESSES: This meeting will be hybrid, held both virtually through
Zoom and in-person at 5600 Fishers Lane in Rockville, Maryland, 20857.
Advance registration is required to attend. Please visit the meeting
website to register. Registration will open in August. The in-person
registration deadline is
[[Page 60644]]
Monday, October 14, 2024, at 5 p.m. ET; registration for virtual
attendance will remain open. Prior to the meeting, each individual
registrant will receive a registration confirmation along with an
access link to the virtual meeting location.
FOR FURTHER INFORMATION CONTACT: Breana Alsworth, Public Health
Analyst, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland
20857; (301) 443-1134; or [email protected].
SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to
the Secretary of HHS on policy, program development, and other matters
of significance concerning the activities under section 222 of the
Public Health Service Act, 42 U.S.C. 217a.
The purpose of CHAC is to advise the Secretary of HHS, CDC
Director, and HRSA Administrator regarding objectives, strategies,
policies, and priorities for the prevention and treatment of HIV, viral
hepatitis, and other STDs, including surveillance, epidemiologic,
behavioral, health services, and laboratory research, identification of
policy issues related to professional education, patient healthcare
delivery, and prevention services; agency policies regarding health
care delivery, research and training; strategic issues influencing the
ability of CDC and HRSA to fulfill their missions' programmatic efforts
to prevent and treat HIV, viral hepatitis, and other STDs; and support
to CDC and HRSA in their development of responses to emerging health
needs related to these issues.
During the October 21-22, 2024, meeting, CHAC will discuss issues
related to re-engaging people with HIV out of care (including data-to-
care strategies and overcoming barriers to care), the use of long-
acting injectables for HIV care and treatment and increasing access to
mental health services for people with HIV and STDs. Agenda items are
subject to change as priorities dictate. Please refer to the CHAC
meeting information page listed above for any updated meeting
information.
Members of the public will have the opportunity to provide
comments. Public participants may also submit written statements as
further described below. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to CHAC should be sent
via the meeting website at https://targethiv.org/events/chac after
registration has opened. Requests for oral comment must be received by
October 11, 2024, at 5:00 p.m. ET to be considered. Written comments
may be submitted to Breana Alsworth ([email protected]) prior
to and up to 10 business days after the meeting. Visit the meeting
information page for additional details: https://targethiv.org/events/chac.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Breana Alsworth
([email protected]) at least 10 business days prior to the
meeting. Since this meeting occurs in a Federal Government building,
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify HRSA of their planned attendance at
least 20 business days prior to the meeting to facilitate their entry
into the building. All attendees are required to present government-
issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-16504 Filed 7-25-24; 8:45 am]
BILLING CODE 4165-15-P
